Supplementary Materials and Methods from Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer
posted on 2023-03-30, 23:29authored byJohn P. Thomson, Raffaele Ottaviano, Elif B. Unterberger, Harri Lempiäinen, Arne Muller, Remi Terranova, Robert S. Illingworth, Shaun Webb, Alastair R.W. Kerr, Marcus J. Lyall, Amanda J. Drake, C. Roland Wolf, Jonathan G. Moggs, Michael Schwarz, Richard R. Meehan
Describes more detailed methods employed in main manuscript and supplementary data.
Funding
Innovative Medicine Initiative Joint Undertaking (IMI JU)
IMI-MARCAR–funded career development fellowships and is now funded by a grant from CEFIC